Adverse events of iron and/ or erythropoiesis-stimulating agent therapy in preoperatively anemic elective surgery patients: a systematic review
dc.contributor.author | Laermans, Jorien | en_ZA |
dc.contributor.author | Van Remoortel, Hans | en_ZA |
dc.contributor.author | Avau, Bert | en_ZA |
dc.contributor.author | Bekkering, Geertruida | en_ZA |
dc.contributor.author | Georgsen, Jorgen | en_ZA |
dc.contributor.author | Manzini, Paola Maria | en_ZA |
dc.contributor.author | Meybohm, Patrick | en_ZA |
dc.contributor.author | Ozier, Yves | en_ZA |
dc.contributor.author | De Buck, Emmy | en_ZA |
dc.contributor.author | Compernolle, Veerle | en_ZA |
dc.contributor.author | Vandekerckhove, Philippe | en_ZA |
dc.date.accessioned | 2024-02-01T07:45:00Z | |
dc.date.available | 2024-02-01T07:45:00Z | |
dc.date.issued | 2022-10-27 | en_ZA |
dc.description | The original publication is available at: https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-022-02081-5 | en_ZA |
dc.description.abstract | Background Iron supplementation and erythropoiesis-stimulating agent (ESA) administration represent the hallmark therapies in preoperative anemia treatment, as reflected in a set of evidence-based treatment recommendations made during the 2018 International Consensus Conference on Patient Blood Management. However, little is known about the safety of these therapies. This systematic review investigated the occurrence of adverse events (AEs) during or after treatment with iron and/or ESAs. | en_ZA |
dc.description.uri | https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-022-02081-5 | en_ZA |
dc.description.version | Publisher’s version | en_ZA |
dc.format.extent | 17 pages | en_ZA |
dc.identifier.citation | Laermans, J. et al. 2022. Adverse events of iron and/or erythropoiesis-stimulating agent therapy in preoperatively anemic elective surgery patients: a systematic review. Syst Rev 11(224):17 pages . doi.10.1186/s13643-022-02081-5 | en_ZA |
dc.identifier.doi | 10.1186/s13643-022-02081-5 | en_ZA |
dc.identifier.issn | 2046-4053 (online) | en_ZA |
dc.identifier.orcid | 0000-0002-6695-6019 | en_ZA |
dc.identifier.uri | https://scholar.sun.ac.za/handle/10019.1/129226 | |
dc.language.iso | en | |
dc.publisher | BioMed Central Ltd | en_ZA |
dc.rights.holder | Authors retain copyright | en_ZA |
dc.title | Adverse events of iron and/ or erythropoiesis-stimulating agent therapy in preoperatively anemic elective surgery patients: a systematic review | en_ZA |
dc.type | Article | en_ZA |